San Diego, CA, United States of America

Ryan Craig

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Illumina Corporation. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ryan Craig

Introduction

Ryan Craig, an inventive mind from San Diego, CA, has made a significant impact in the field of molecular biology through his work with polymerases. As an inventor, Ryan holds one patent that holds promise for advancements in genetic research and biotechnology.

Latest Patents

Ryan Craig's notable patent, titled "Polymerases, compositions, and methods of use," presents innovative altered polymerase enzymes designed for improved nucleotide incorporation. This invention focuses on enhancing the efficiency of nucleotide analogues incorporation while maintaining low pre-phasing rates, particularly when utilizing ambiently stored polymerases. The development opens new avenues in both research and practical applications.

Career Highlights

Currently, Ryan works at Illumina Corporation, a leading company in genomic sequencing and analysis technologies. His contributions at Illumina not only bolster the company’s mission but also play a pivotal role in pushing the boundaries of genetic research.

Collaborations

Ryan collaborates with talented coworkers such as Misha Golynskiy and Mariko Matsuura. These partnerships within Illumina Corporation enhance the innovative workflow, fostering a dynamic environment for the exploration and application of cutting-edge biotechnology solutions.

Conclusion

Ryan Craig stands out as a notable inventor whose work has the potential to revolutionize genetic methodologies. His patent exemplifies the integration of scientific exploration and practical application, making meaningful contributions to the field and paving the way for future innovations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…